The COVID-19 pandemic resulted in federal policy changes related to telehealth use that allowed states to maximize access to medications for opioid use disorder (MOUD) through telehealth.
Breadcrumb
- Home
- Resources and Tools
Resources and Tools
Individuals who have HIV who also use drugs experience increased age-matched morbidity and mortality in comparison with those with HIV who do not use drugs.
This CDC report provides updated data related to HIV prevalence among people who inject drugs, documenting findings that underscore the need for low-barrier access to comprehensive and integrated needs-based syringe service programs for necessary prevention and
This document describes the critical role that peers have in developing and delivering care for people with HIV and OUD and how a state’s Medicaid program can serve as an essential fiscal resource in supporting peer services.
This tool aims to assist HIV primary care teams that work in a range of clinical settings to develop and provide enhanced integration of behavioral health (BH) services.
This discussion guide is intended to elicit a comprehensive and concrete conversation about language, stigma, and discrimination as a means of strengthening care systems and ensuring that people who seek care for HIV and/or substance use disorders, including opioid use disorder, are treated with
This package is a learning tool designed for health departments and community-based organizations newly offering syringe services programs (SSPs) with the purpose of indexing the materials needed for safer injection, what to offer at a syringe services program, and how to explain what materials a
This webinar companion guide offers attendees a resource to supplement the information covered during a webinar and extend the webinar’s benefits beyond the allotted presentation time. It contains:
This tool focuses on the role of stigma at the intersection of HIV and OUD systems, and introduces opportunities for intervention at the systems level.
In Los Angeles, New York, Houston, Philadelphia, and Washington, D.C., a National Institutes of Health funded clinical trial, known as INTEGRA, is evaluating the efficacy of delivering integrated HIV and substance use disorder care via mobile clinics.
Pagination
- Previous page ‹‹
- Page 2
- Next page ››